-
Teenager Flagg leads Mavericks to upset of Pistons
-
Australia's Head fires quickfire 68 as England's Ashes hopes fade
-
Conway falls for 227 as New Zealand declare at 575-8 in West Indies Test
-
Japan hikes interest rates to 30-year-high
-
Brazil's top court strikes down law blocking Indigenous land claims
-
Conway falls for 227 as New Zealand pass 500 in West Indies Test
-
'We are ghosts': Britain's migrant night workers
-
Asian markets rise as US inflation eases, Micron soothes tech fears
-
Giant lanterns light up Christmas in Catholic Philippines
-
TikTok: key things to know
-
Putin, emboldened by Ukraine gains, to hold annual presser
-
Deportation fears spur US migrants to entrust guardianship of their children
-
Upstart gangsters shake Japan's yakuza
-
Trump signs $900 bn defense policy bill into law
-
Stokes's 83 gives England hope as Australia lead by 102 in 3rd Test
-
Go long: the rise and rise of the NFL field goal
-
Australia announces gun buyback, day of 'reflection' after Bondi shooting
-
New Zealand Cricket chief quits after split over new T20 league
-
England all out for 286, trail Australia by 85 in 3rd Test
-
Australian announces gun buyback, day of 'reflection' after Bondi shooting
-
Joshua takes huge weight advantage into Paul fight
-
TikTok signs joint venture deal to end US ban threat
-
Conway's glorious 200 powers New Zealand to 424-3 against West Indies
-
WNBA lockout looms closer after player vote authorizes strike
-
Honduras begins partial vote recount in Trump-dominated election
-
Nike shares slump as China struggles continue
-
Hundreds swim, float at Bondi Beach to honour shooting victims
-
Crunch time for EU leaders on tapping Russian assets for Ukraine
-
Pope replaces New York's pro-Trump Cardinal with pro-migrant Chicagoan
-
Trump orders marijuana reclassified as less dangerous drug
-
Rams ace Nacua apologizes over 'antisemitic' gesture furor
-
McIlroy wins BBC sports personality award for 2025 heroics
-
Napoli beat Milan in Italian Super Cup semi-final
-
Violence erupts in Bangladesh after wounded youth leader dies
-
EU-Mercosur deal delayed as farmers stage Brussels show of force
-
US hosting new Gaza talks to push next phase of deal
-
Chicago Bears mulling Indiana home over public funding standoff
-
Trump renames Kennedy arts center after himself
-
Trump rebrands housing supplement as $1,776 bonuses for US troops
-
Harrison Ford to get lifetime acting award
-
Trump health chief seeks to bar trans youth from gender-affirming care
-
Argentine unions in the street over Milei labor reforms
-
Trump signs order reclassifying marijuana as less dangerous
-
Famed Kennedy arts center to be renamed 'Trump-Kennedy Center'
-
US accuses S.Africa of harassing US officials working with Afrikaners
-
Brazil open to EU-Mercosur deal delay as farmers protest in Brussels
-
Wounded Bangladesh youth leader dies in Singapore hospital
-
New photo dump fuels Capitol Hill push on Epstein files release
-
Brazil, Mexico seek to defuse US-Venezuela crisis
-
Assange files complaint against Nobel Foundation over Machado win
A New Era in Patient Affordability: TailorMed Builds the Industry Infrastructure to Tackle Medication Costs at Scale
Facing Soaring Drug Prices, TailorMed's Affordability Network Bridges Care and Financial Relief
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Millions of Americans today face an impossible choice between affording life-saving medications and risking severe financial hardship. TailorMed is tackling this challenge by bringing healthcare providers, specialty pharmacies, life science companies, and patients together in one coordinated network - streamlining access to financial assistance so patients can stay on-therapy and achieve better outcomes.
On April 29, at 4:00 p.m. PT during Asembia AXS25, TailorMed CEO and co-founder Srulik Dvorsky will moderate "It Takes a Network: Tackling Affordability Together," joined by senior leaders from Pfizer, Walgreens Specialty Pharmacy, MetroHealth, and Pink Fund. This strategic roundtable will demonstrate how TailorMed's collaborative network turns these partnerships into real-world solutions that ease patient financial burdens and improve care.
"The soaring cost of medications is creating an untenable situation for patients, forcing too many to choose financial stability over essential treatments," said Dvorsky. "Our colleagues at Pfizer, Walgreens, Pink Fund, and MetroHealth share our passion and recognize the need to fundamentally change how affordability is managed, and ensure patients can access vital treatments without financial hardship. We are grateful that our partners will join this panel discussion to share their expertise."
TailorMed's extensive affordability network, the largest of its kind, ensures patients find the care pathways they need, when they need them. By bringing together healthcare providers, specialty pharmacies, life science companies, and nonprofit organizations, TailorMed leverages cutting-edge technology and collaborative partnerships to eliminate financial barriers, dramatically improving patient outcomes and easing systemic healthcare burdens.
TailorMed representatives will also be available throughout the summit at booth #2014 for discussions and demonstrations of their affordability solutions.
For additional information on TailorMed's innovative approaches to medication affordability, visit https://tailormed.co/.
About TailorMed
TailorMed is a comprehensive platform dedicated to removing financial barriers across the medication continuum - from affordability and access to adherence. TailorMed transforms healthcare collaboration among patients, providers, pharmacies, life sciences companies, and payers, ensuring every patient receives the treatments they need promptly. With the nation's largest Affordability Network deployed in more than 800 hospitals, 1,300 clinics, and 1,400 pharmacies, TailorMed enables stakeholders to deliver seamless patient experiences and drive better healthcare outcomes. Learn more at tailormed.co.
Media Contact:
Jennifer Martin, VP, Marketing
312.882.4402 | [email protected]
PR Contact:
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
LinkedIn
𝕏: @Parallel_PR
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
P.Hernandez--AT